Publications

Back to Publications

Find coverage of the latest original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.

Belimumab Use During Pregnancy: Interim Results of the Belimumab Pregnancy Registry

Birth Defects Res. 2022. Epub ahead of print doi: 10.1002/bdr2.2091

There was no pattern or common mechanism of birth defects associated with belimumab within the Belimumab Pregnancy Registry (BPR) data.

The BPR was created to evaluate pregnancy and infant outcomes following belimumab exposure, as there are limited data regarding its use in pregnancy. Juliao, et al. descriptively report the data up to March 8, 2021, with limited conclusions.

Keywords:


LinkedIn